Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Biodistribution and Cellular Internalization of Inactivated SARS-CoV-2 in Wild-Type Mice

A. Hudák, G. Morgan, J. Bacovsky, R. Patai, TF. Polgár, A. Letoha, A. Pettko-Szandtner, C. Vizler, L. Szilák, T. Letoha

. 2022 ; 23 (14) : . [pub] 20220709

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22025249

Grantová podpora
807015 Innovative Medicines Initiative
863214 European Union
2017-2.3.6-TÉT-CN-2018-00023 National Research, Development and Innovation Office
2020-1.1.6-JÖVŐ-2021-00012 National Research, Development and Innovation Office

Despite the growing list of identified SARS-CoV-2 receptors, the human angiotensin-converting enzyme 2 (ACE2) is still viewed as the main cell entry receptor mediating SARS-CoV-2 internalization. It has been reported that wild-type mice, like other rodent species of the Muridae family, cannot be infected with SARS-CoV-2 due to differences in their ACE2 receptors. On the other hand, the consensus heparin-binding motif of SARS-CoV-2's spike protein, PRRAR, enables the attachment to rodent heparan sulfate proteoglycans (HSPGs), including syndecans, a transmembrane HSPG family with a well-established role in clathrin- and caveolin-independent endocytosis. As mammalian syndecans possess a relatively conserved structure, we analyzed the cellular uptake of inactivated SARS-CoV-2 particles in in vitro and in vivo mice models. Cellular studies revealed efficient uptake into murine cell lines with established syndecan-4 expression. After intravenous administration, inactivated SARS-CoV-2 was taken up by several organs in vivo and could also be detected in the brain. Internalized by various tissues, inactivated SARS-CoV-2 raised tissue TNF-α levels, especially in the heart, reflecting the onset of inflammation. Our studies on in vitro and in vivo mice models thus shed light on unknown details of SARS-CoV-2 internalization and help broaden the understanding of the molecular interactions of SARS-CoV-2.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22025249
003      
CZ-PrNML
005      
20221031100535.0
007      
ta
008      
221017s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms23147609 $2 doi
035    __
$a (PubMed)35886958
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Hudák, Anett $u Pharmacoidea Ltd., H-6726 Szeged, Hungary
245    10
$a Biodistribution and Cellular Internalization of Inactivated SARS-CoV-2 in Wild-Type Mice / $c A. Hudák, G. Morgan, J. Bacovsky, R. Patai, TF. Polgár, A. Letoha, A. Pettko-Szandtner, C. Vizler, L. Szilák, T. Letoha
520    9_
$a Despite the growing list of identified SARS-CoV-2 receptors, the human angiotensin-converting enzyme 2 (ACE2) is still viewed as the main cell entry receptor mediating SARS-CoV-2 internalization. It has been reported that wild-type mice, like other rodent species of the Muridae family, cannot be infected with SARS-CoV-2 due to differences in their ACE2 receptors. On the other hand, the consensus heparin-binding motif of SARS-CoV-2's spike protein, PRRAR, enables the attachment to rodent heparan sulfate proteoglycans (HSPGs), including syndecans, a transmembrane HSPG family with a well-established role in clathrin- and caveolin-independent endocytosis. As mammalian syndecans possess a relatively conserved structure, we analyzed the cellular uptake of inactivated SARS-CoV-2 particles in in vitro and in vivo mice models. Cellular studies revealed efficient uptake into murine cell lines with established syndecan-4 expression. After intravenous administration, inactivated SARS-CoV-2 was taken up by several organs in vivo and could also be detected in the brain. Internalized by various tissues, inactivated SARS-CoV-2 raised tissue TNF-α levels, especially in the heart, reflecting the onset of inflammation. Our studies on in vitro and in vivo mice models thus shed light on unknown details of SARS-CoV-2 internalization and help broaden the understanding of the molecular interactions of SARS-CoV-2.
650    _2
$a angiotensin-konvertující enzym 2 $x metabolismus $7 D000085962
650    _2
$a zvířata $7 D000818
650    12
$a COVID-19 $x metabolismus $x virologie $7 D000086382
650    _2
$a heparansulfát proteoglykany $x metabolismus $7 D019812
650    _2
$a lidé $7 D006801
650    _2
$a savci $x metabolismus $7 D008322
650    _2
$a myši $7 D051379
650    12
$a SARS-CoV-2 $x metabolismus $7 D000086402
650    _2
$a syndekany $x metabolismus $7 D053667
650    12
$a tkáňová distribuce $x fyziologie $7 D014018
650    12
$a internalizace viru $7 D053586
655    _2
$a časopisecké články $7 D016428
700    1_
$a Morgan, Gareth $u Boeckeler Instruments, Inc., Tucson, AZ 85714, USA
700    1_
$a Bacovsky, Jaromir $u Delong Instruments a.s., 612 00 Brno, Czech Republic
700    1_
$a Patai, Roland $u Institute of Biophysics, Biological Research Centre, H-6726 Szeged, Hungary $1 https://orcid.org/0000000253022815
700    1_
$a Polgár, Tamás F $u Institute of Biophysics, Biological Research Centre, H-6726 Szeged, Hungary $u Theoretical Medicine Doctoral School, Faculty of Medicine, University of Szeged, H-6720 Szeged, Hungary
700    1_
$a Letoha, Annamária $u Department of Medicine, Albert Szent-Györgyi Clinical Center, Faculty of Medicine, University of Szeged, H-6720 Szeged, Hungary
700    1_
$a Pettko-Szandtner, Aladar $u Laboratory of Proteomics Research, Biological Research Centre, H-6726 Szeged, Hungary
700    1_
$a Vizler, Csaba $u Institute of Biochemistry, Biological Research Centre, H-6726 Szeged, Hungary
700    1_
$a Szilák, László $u Pharmacoidea Ltd., H-6726 Szeged, Hungary
700    1_
$a Letoha, Tamás $u Pharmacoidea Ltd., H-6726 Szeged, Hungary $1 https://orcid.org/0000000260354009
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 23, č. 14 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35886958 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20221031100533 $b ABA008
999    __
$a ok $b bmc $g 1854780 $s 1176539
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 23 $c 14 $e 20220709 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a 807015 $p Innovative Medicines Initiative
GRA    __
$a 863214 $p European Union
GRA    __
$a 2017-2.3.6-TÉT-CN-2018-00023 $p National Research, Development and Innovation Office
GRA    __
$a 2020-1.1.6-JÖVŐ-2021-00012 $p National Research, Development and Innovation Office
LZP    __
$a Pubmed-20221017

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...